Live
Nitric Oxide Therapy (Ref: 2020/S 029-068821 )
Background
This Framework Agreement for the supply of Nitric Oxide Therapy enables buyers a flexible procurement solution to safely and efficiently procure all products needed for the supply of nitric oxide. Nitric oxide is a medical gas commonly used in intensive care units to treat pulmonary hypertension.
Benefits
- Simplify the procurement process for public sector organisations to procure nitric oxide
- Discounted prices under certain conditions
- Streamlined contract management process for the overarching framework
Start date
05/05/2020
End date
05/05/2024
Contract type
Framework Agreement
Framework owner
NHS London Procurement Partnership
ABI
0.5%
List of suppliers
BOC Ltd, BTG Gases
Access the framework documents
If you have a login to our sharepoint, you can access the framework documents below.
Not a member or don't have a login? Please email pharmacy@eoecph.nhs.uk to request access to framework documentation.